Liu TH, Zuo L, Guo DQ, Chai XL, Xu J, Cui ZR, et al
7What Are the Treatment Options Available for Acquired Melanocytic Nevus
As a treatment, it not only mitigates the gene's activity but also ensures a holistic reduction in melanocyte function
Hurst RH
This is the most frequently reported effect and is inherent to GHRP-6's mechanism Mild water retention and peripheral edema, particularly during the first 2 to 4 weeks Transient flushing, warmth, or dizziness immediately post-injection Injection site reactions (redness, minor swelling) Less Common: Tingling or numbness in the extremities (hands and feet), related to GH-mediated fluid shifts Head rush or lightheadedness shortly after administration Drowsiness, particularly with evening doses Dose-Dependent (above saturation dose): Elevated cortisol via ACTH stimulation
Conclusion Liraglutide was associated with the highest risk of clinically relevant cholelithiasis than semaglutide, and dulaglutide in patients with T2D
